Revolution Medicines, Inc. (RVMDW)

NASDAQ: RVMDW · Real-Time Price · USD · Warrants
0.2395
+0.0145 (6.44%)
Jul 8, 2025, 4:00 PM - Market closed
6.44%
Market Cap 6.79B
Revenue (ttm) n/a
Net Income (ttm) -697.51M
Shares Out 186.27M
EPS (ttm) -4.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 59,555
Open 0.2250
Previous Close 0.2250
Day's Range 0.2079 - 0.2400
52-Week Range 0.0305 - 0.8000
Beta 1.10
Analysts n/a
Price Target n/a
Earnings Date Feb 26, 2025

About RVMDW

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236)... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 534
Stock Exchange NASDAQ
Ticker Symbol RVMDW
Full Company Profile

News

There is no news available yet.